Artificial in the news

Robochat with Nikhita Singh & Bob Gantzer - Accelerate Scientific Discovery with Automation

During Playground Global's Robochat series, CPO & Co-Founder Nikhita Singh and Beam Therapeutics' Director of Lab Automation share their perspective on how lab automation is transforming the life sciences and what's next.
Read more

Accessible Automation at Beam Therapeutics

To overcome the challenges of accessibility in lab automation, Beam Therapeutics partnered with Artificial. Learn more about Beam's automation journey and how they made automation accessible to all with Artificial.
Read more

Welcoming Artificial to the M12 Portfolio

Kouki Haraski, PhD MBA of M12, Microsoft's venture arm, welcomes Artificial as the lead of their Series A round.
Read more

Artificial raises $21M led by Microsoft’s M12 for a lab automation platform aimed at life sciences R&D

Artificial's $21.5M Series A round will fund the further development of their platform so they can accelerate the rate of discovery in labs.
Read more

Artificial Raises $21.5M to Accelerate Life Science Breakthroughs

Artificial raised a $21.5M Series A investment round led by led by M12, Microsoft’s venture fund, along with Playground Global and AME Cloud Ventures.
Read more
crossmenuchevron-downarrow-leftarrow-right